Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| BioMarin Pharmaceutical Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| BioMarin Pharmaceutical Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| BioMarin Pharmaceutical Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| BioMarin Pharmaceutical Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 | 8 | 1 |
| BioMarin Pharmaceutical Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 | 9 | 1 |
| BioMarin Pharmaceutical Inc., Medical Equipment, Deal Details | 10 | 10 |
| Partnerships | 10 | 1 |
| Zacharon Enters Into Licensing Agreement With Shire For Sensi Pro Assay | 10 | 1 |
| Zacharon Pharma Enters Into Licensing Agreement With Arup Labs For Sensi-Pro Assay | 11 | 1 |
| Equity Offering | 12 | 1 |
| BioMarin Pharma Prices Public Offering of Shares for USD720 Million | 12 | 2 |
| BioMarin Pharma Completes Public Offering Of Shares For US$119.3 Million | 14 | 1 |
| Debt Offering | 15 | 1 |
| BioMarin Pharma Completes Public Offering Of Notes Due 2018 For US$375 Million | 15 | 2 |
| BioMarin Pharma Completes Public Offering Of Notes Due 2020 For US$375 Million | 17 | 2 |
| Acquisition | 19 | 1 |
| Roche Rumored To Acquire BioMarin Pharma For US$13.5 Billion | 19 | 1 |
| BioMarin Pharmaceutical Inc. - Key Competitors | 20 | 1 |
| Key Employees | 21 | 2 |
| Locations And Subsidiaries | 23 | 2 |
| Head Office | 23 | 1 |
| Other Locations &Subsidiaries | 23 | 2 |
| Recent Developments | 25 | 1 |
| Strategy And Business Planning | 25 | 1 |
| Sep 30, 2015: Parent Project Muscular Dystrophy Launches Next Phase of Genetic Testing Program, Decode Duchenne in collaboration with BioMarin Pharmaceutical PTC Therapeutics, and Sarepta Therapeutics | 25 | 1 |
| Financial Announcements | 26 | 1 |
| Apr 28, 2016: BioMarin Announces First Quarter 2016 Financial Results | 26 | 2 |
| Feb 25, 2016: BioMarin Announces Fourth Quarter and Full Year 2015 Financial Results | 28 | 2 |
| Aug 03, 2015: BioMarin Announces Second Quarter 2015 Financial Results and Company Update | 30 | 2 |
| Apr 30, 2015: BioMarin Announces First Quarter 2015 Financial Results and Company Update | 32 | 2 |
| Feb 25, 2015: BioMarin Announces Fourth Quarter and Full Year 2014 Financial Results | 34 | 2 |
| Corporate Communications | 36 | 1 |
| Jul 18, 2016: BioMarin Appoints Two BioPharmaceutical Veterans to Board of Directors, Willard Dere, M.D. and Kathryn E. Falberg | 36 | 2 |
| Jan 04, 2016: BioMarin Announces Addition of David Pyott, Former Allergan Chairman and CEO, to Company's Board of Directors | 38 | 1 |
| Jan 07, 2015: BioMarin Announces Planned Changes to Board of Directors Leadership Structure | 39 | 1 |
| Appendix | 40 | 1 |
| Methodology | 40 | 1 |
| About GlobalData | 40 | 1 |
| Contact Us | 40 | 1 |
| Disclaimer | 40 | 1 |